EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study

Daniel Arnés-García iD, Jorge Calderón-Parra, Marina Calvo-Salvador, Carmen Herrero-Rodríguez, Svetlana Sadyrbaeva-Dolgova iD, Carmen Hidalgo-Tenorio iD

Antibiotics · 05.05.2026 · 15 (5) · 466

DOI: 10.3390/antibiotics15050466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 05.05.2026. Verfasst von Daniel Arnés-García und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Ceftaroline fosamil (CFT) is a fifth-generation cephalosporin approved in Spain for skin and soft tissue infections and community-acquired pneumonia. CFT may also be useful against endovascular infections. This real-world study aimed to evaluate its effectiveness and safety in patients with Gram-positive (GP) infective endocarditis (IE).

Methods

This observational, retrospective multicenter study enrolled adults with GP-IE treated with CFT for ≥48 h. Recruitment extended from CFT incorporation in participating hospitals through May 2024. Data were gathered on demographic, clinical, and microbiological variables, adverse effects, overall and IE-related mortality, relapses, and a composite unfavorable outcome.

Results

Seventy-six patients (65.8% male) were enrolled, with a mean age of 68.9 ± 12.8 years and an age-adjusted Charlson index of 4; 55.3% had previous moderate/severe valvular heart disease, 35.5% had atrial fibrillation, 34.2% chronic heart failure, 17.1% chronic kidney disease, and 22.4% septic shock. IE was native valve-related in 53.9%, involving the aortic valve in 38.2% and the mitral in 30.3%. Staphylococcus aureus was isolated in 48.7%, being methicillin-resistant in 40.5% of cases. CFT was salvage therapy in 65.8% and combined with other antibiotics in 94.7%. Valve replacement was indicated in 64.5% but performed in only 67.3% of these. At six months, the adverse effect rate was 9.2%, overall crude mortality 38.2%, infection-related mortality 28.9%, and composite unfavorable outcome 40.1%. In multivariate analysis, mortality-related factors were age-adjusted Charlson index, septic shock, and methicillin-sensitive S. aureus.

Conclusions

CFT showed favorable outcomes and acceptable safety in the real-life treatment of GP-related IE in clinically complex patients with high comorbidity and previous antibiotic therapy failures.

Schlagwörter

Stichwörter der Autor:innen

Staphylococcus aureusceftaroline fosamilinfective endocarditisreal-world study

Autor:innen und Institutionen

  • Internal Medicine Department, Hospital Universitario Virgen de las Nieves, 18014 Granada, Spain.
  • Infectious Diseases Unit, Hospital Puerta de Hierro de Majadahonda, 28222 Madrid, Spain.
  • Pharmacy Department, Hospital Puerta de Hierro de Majadahonda, 28222 Madrid, Spain.
  • Infectious Diseases and Microbiology Unit, Complejo Hospitalario de Jaén, 23007 Jaén, Spain.
  • Pharmacy Department, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18014 Granada, Spain.
  • Infectious Diseases Unit, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18014 Granada, Spain.

ORCID-Profile: Daniel Arnés-García, Svetlana Sadyrbaeva-Dolgova, Carmen Hidalgo-Tenorio

Zitieren

APA

Arnés-García, D., Calderón-Parra, J., Calvo-Salvador, M., Herrero-Rodríguez, C., Sadyrbaeva-Dolgova, S., & Hidalgo-Tenorio, C. (2026). Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study. Antibiotics, 15(5), 466. https://doi.org/10.3390/antibiotics15050466

Vancouver

Arnés-García D, Calderón-Parra J, Calvo-Salvador M, Herrero-Rodríguez C, Sadyrbaeva-Dolgova S, Hidalgo-Tenorio C. Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study. Antibiotics. 2026;15(5):466. doi:10.3390/antibiotics15050466

BibTeX
@article{ArnsGarca2026,
  author = {Arnés-García, Daniel and Calderón-Parra, Jorge and Calvo-Salvador, Marina and Herrero-Rodríguez, Carmen and Sadyrbaeva-Dolgova, Svetlana and Hidalgo-Tenorio, Carmen},
  title = {Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {5},
  pages = {466},
  doi = {10.3390/antibiotics15050466}
}
Kostenlos starten →